The biocompatibility and performance of the entire Visage range have been clinically demonstrated. The range complies with all safety standards required by health authorities and has been CE marked since 2020. Visage is registered and launched in more than 20 countries around the world. With more than 5 years of clinical use. nearly 2 million syringes have been injected at 0.02% adverse event. The range has established itself among the leaders in the aesthetic market.